Exemplary case from study group 1 (supplement)
What is an antioxidant, and why is it important
38 In a nationwide cohort study of 120,054 patients with type 2 diabetes with a median follow up of 7.4 years, there was an 11% reduction in the rate of dementia when GLP-1 receptor agonists were used as a second-line treatment compared with other glucose-lowering therapies and the risk reduced with increasing duration of GLP-1 receptor agonist exposure (liraglutide in 95% of patients)
A structured risk assessment should include your baseline blood pressure, dehydration history, concurrent medications that lower blood pressure, and existing vestibular or neurological conditions
References Albrecht S, Jung S, Mller R, et al
They are changing the landscape and addressing obesity in a way weve not seen before. Key points: Typically, pharmacies offer pre-approved FDA medications